News

Weight reduction decreases atrial fibrillation symptoms severity

22.11.20131876

A new study published in the Journal of the American Medical Association has shown that a structured weight reduction programme for highly symptomatic atrial fibrillation patients helps to reduce symptom burden and severity and also helps to reduce antiarrhythmic drug use.

DAYLIGHT: Vitamin D Therapy Did Not Lower BP in High Risk Individuals

21.11.20131836

In patients with pre- or stage 1 hypertension and vitamin D deficiency, high-dose vitamin D supplementation was not effective at improving blood pressure, according to results of the DAYLIGHT trial presented Nov. 19 at AHA 2013.

Does Aspirin Intake at Bedtime Decrease BP and Morning Peak of Platelet Reactivity?

20.11.20131800

The timing of aspirin administration may result in a reduced risk of cardiovascular events, according to the Aspirin in Reduction of Tension II trial, presented Nov. 19 as part of AHA 2013.

NIAMI: Nitrites in AMI

19.11.20131856

In patients with acute ST-elevation myocardial infarction (STEMI), sodium nitrite administered intravenously (iv) prior to reperfusion, "did not reduce infarct size," according to results of the Nitrites In Acute Myocardial Infarction (NIAMI) Trial presented Nov. 17 as part of AHA 2013.

CATIS: China Antihypertensive Trial in Acute Ischemic Stroke Patients

18.11.20132395

Antihypertensive therapy given during the acute phase of ischemic stroke does not reduce the short-term risk of death or dependency, according to results of the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS) trial presented Nov. 17 as part of AHA 2013, and published simultaneously in the Journal of the American Medical Association.

A Novel Prion Disease Associated with Diarrhea and Autonomic Neuropathy

16.11.20131802

Human prion diseases, although variable in clinicopathological phenotype, generally present as neurologic or neuropsychiatric conditions associated with rapid multifocal central nervous system degeneration that is usually dominated by dementia and cerebellar ataxia.

Clinical strategies for selecting oral anticoagulants in atrial fibrillation patients

15.11.20132122

Patients with atrial fibrillation have a five- to seven-fold greater risk of stroke than the general population, and approximately 20% of ischaemic strokes are due to this arrhythmia. Vitamin K antagonists such as warfarin have been the long-standing anticoagulants for stroke prevention in atrial fibrillation.